EFM
E Fund Management Portfolio holdings
AUM
$2.1B
1-Year Return
23.31%
This Quarter Return
+3.74%
1 Year Return
+23.31%
3 Year Return
+155.42%
5 Year Return
–
10 Year Return
–
AUM
$2.09B
AUM Growth
+$101M
(+5.1%)
Cap. Flow
+$51.3M
Cap. Flow
% of AUM
2.45%
Top 10 Holdings %
Top 10 Hldgs %
52.15%
Holding
437
New
42
Increased
236
Reduced
93
Closed
39
Top Buys
| 1 |
Apple
AAPL
|
$22.7M |
| 2 |
Microsoft
MSFT
|
$17M |
| 3 |
NVIDIA
NVDA
|
$15.1M |
| 4 |
Amazon
AMZN
|
$13.7M |
| 5 |
Meta Platforms (Facebook)
META
|
$13.3M |
Top Sells
| 1 |
Pinduoduo
PDD
|
$95M |
| 2 |
KE Holdings
BEKE
|
$15.8M |
| 3 |
Full Truck Alliance
YMM
|
$10.2M |
| 4 |
Tencent Music
TME
|
$10M |
| 5 |
TSMC
TSM
|
$8.26M |
Sector Composition
| 1 | Technology | 37.79% |
| 2 | Consumer Discretionary | 26.64% |
| 3 | Communication Services | 10.64% |
| 4 | Healthcare | 6.89% |
| 5 | Financials | 6.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Jabil
JBL
$22.3B
| $315K | 0.02% |
2,318
| – | – |
|
302
Henry Schein
HSIC
$8.22B
| $315K | 0.02% |
4,596
-56
| -1% | -$3.84K |
|
303
F5
FFIV
$18.1B
| $314K | 0.02% |
1,180
| – | – |
|
304
Acadia Pharmaceuticals
ACAD
$4.3B
| $311K | 0.01% |
18,718
+8,090
| +76% | +$134K |
|
305
Align Technology
ALGN
$9.76B
| $310K | 0.01% |
1,954
+421
| +27% | +$66.9K |
|
306
Soleno Therapeutics
SLNO
$3.7B
| $310K | 0.01% |
4,332
-371
| -8% | -$26.5K |
|
307
Bio-Techne
TECH
$8.23B
| $309K | 0.01% |
5,262
+621
| +13% | +$36.4K |
|
308
Marsh & McLennan
MMC
$101B
| $308K | 0.01% |
1,263
+47
| +4% | +$11.5K |
|
309
Veracyte
VCYT
$2.48B
| $308K | 0.01% |
10,371
+3,979
| +62% | +$118K |
|
310
Deere & Co
DE
$128B
| $307K | 0.01% |
654
+24
| +4% | +$11.3K |
|
|
CMCM
311
Cheetah Mobile
CMCM
$179M
| $305K | 0.01% |
+71,363
| New | +$305K |
|
312
Viatris
VTRS
$12B
| $302K | 0.01% |
34,703
+6,156
| +22% | +$53.6K |
|
313
Ultragenyx Pharmaceutical
RARE
$3.01B
| $301K | 0.01% |
8,300
+1,100
| +15% | +$39.8K |
|
314
Zebra Technologies
ZBRA
$15.8B
| $300K | 0.01% |
1,061
| – | – |
|
315
Duke Energy
DUK
$94B
| $299K | 0.01% |
2,450
+577
| +31% | +$70.4K |
|
316
Eaton
ETN
$136B
| $297K | 0.01% |
1,091
+33
| +3% | +$8.97K |
|
317
Recursion Pharmaceuticals
RXRX
$1.97B
| $296K | 0.01% |
55,925
+13,604
| +32% | +$72K |
|
318
Gen Digital
GEN
$18.2B
| $292K | 0.01% |
11,008
| – | – |
|
319
Chubb
CB
$112B
| $291K | 0.01% |
964
+36
| +4% | +$10.9K |
|
320
Teradyne
TER
$19B
| $290K | 0.01% |
3,505
-20,125
| -85% | -$1.66M |
|
321
Rhythm Pharmaceuticals
RYTM
$6.95B
| $286K | 0.01% |
+5,396
| New | +$286K |
|
322
Western Digital
WDC
$31.4B
| $283K | 0.01% |
7,012
-2,265
| -24% | -$91.6K |
|
323
Akero Therapeutics
AKRO
$3.52B
| $280K | 0.01% |
+6,924
| New | +$280K |
|
324
Charles River Laboratories
CRL
$7.99B
| $279K | 0.01% |
1,853
+33
| +2% | +$4.97K |
|
325
Arthur J. Gallagher & Co
AJG
$77B
| $277K | 0.01% |
+803
| New | +$277K |
|